Panacea Life Sciences Holdings, Inc. (PLSH)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.38 Million | 1.62 Million | 2.05 Million | 9.01 Million | 345.68 Thousand | - |
| Cost of Revenue | 6.47 Million | 1.23 Million | 1.51 Million | 7.02 Million | 2.04 Million | - |
| Gross Profit | -4.08 Million | 396.47 Thousand | 540.57 Thousand | 1.99 Million | -1.7 Million | - |
| Operating Expenses | 2.36 Million | 5.79 Million | 6.08 Million | 7.25 Million | 8.97 Million | 2.43 Million |
| Selling, General and Administrative Expenses | 1.45 Million | 1.09 Million | 1.51 Million | 2.8 Million | 8.95 Million | 2.13 Million |
| Research and Development Expenses | - | - | - | - | 22.1 Thousand | 300 Thousand |
| Other Expenses | - | 4.7 Million | 4.56 Million | 4.44 Million | 4.11 Million | 2.13 Million |
| Cost and Expenses | 7.93 Million | 7.02 Million | 7.6 Million | 14.27 Million | 11.01 Million | 2.43 Million |
| Operating Income | -5.54 Million | -5.39 Million | -5.54 Million | -5.25 Million | -10.67 Million | -2.43 Million |
| Interest Expense | 683.23 Thousand | 2.04 Million | 1.1 Million | 1.51 Million | 479.11 Thousand | -464.47 Thousand |
| Income Tax Expense | - | 1.95 Million | 1.34 Million | 1.76 Million | -537.46 Thousand | -161.14 Thousand |
| Earnings before Tax | -8.01 Million | -9.14 Million | -4.78 Million | -5.23 Million | -10.01 Million | -4.33 Million |
| Net Income | -8.01 Million | -11.09 Million | -6.12 Million | -6.99 Million | -9.48 Million | -4.33 Million |
| Earnings Per Share Basic | -0.48 | -0.75 | -0.34 | -0.41 | -7.83 | -25.49 |
| Earnings Per Share Diluted | -0.48 | -0.75 | -0.34 | -0.41 | -7.83 | -25.49 |
| Weighted Average Shares Outstanding | 16.62 Million | 14.86 Million | 17.82 Million | 16.91 Million | 1.21 Million | 170.14 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 16.62 Million | 14.86 Million | 17.82 Million | 16.91 Million | 1.21 Million | 170.14 Thousand |
| Gross Margin | -1.71 | 0.24 | 0.26 | 0.22 | -4.92 | - |
| EBIT Margin | -1.99 | -2.09 | -2.11 | -0.52 | -28.29 | - |
| Profit Margin | -3.36 | -6.82 | -2.97 | -0.78 | -27.43 | - |
| EBITDA | -4.74 Million | -5.36 Million | -1.93 Million | -2.02 Million | -8.64 Million | -3.47 Million |
| Earnings Before Tax Margin | -2.33 | -3.32 | -2.69 | -0.58 | -30.87 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.17 Million | 1.05 Million | 2.38 Million | 960.49 Thousand | 347.85 Thousand | 399.12 Thousand |
| Cost of Revenue | 453.04 Thousand | 390.28 Thousand | 2.11 Million | 635.38 Thousand | 201.23 Thousand | 196.31 Thousand |
| Gross Profit | 721.11 Thousand | 666.16 Thousand | 265.49 Thousand | 325.11 Thousand | 146.61 Thousand | 202.81 Thousand |
| Operating Expenses | 1.72 Million | 1.72 Million | 5.81 Million | 2.09 Million | 1.56 Million | 1.27 Million |
| Selling, General and Administrative Expenses | 1.72 Million | 1.72 Million | - | 2.09 Million | 276.72 Thousand | 145.21 Thousand |
| Research and Development Expenses | - | - | - | 422.72 Thousand | - | -422.72 Thousand |
| Other Expenses | 2380.00 | 36.26 Thousand | - | -1.35 Million | 41.53 Thousand | 41.53 Thousand |
| Cost and Expenses | 2.17 Million | 2.11 Million | 7.93 Million | 2.72 Million | 1.76 Million | 1.47 Million |
| Operating Income | -1 Million | -1.05 Million | -5.54 Million | -1.76 Million | -1.41 Million | -1.07 Million |
| Interest Expense | 459.98 Thousand | 429.67 Thousand | 683.23 Thousand | 412.19 Thousand | 396.58 Thousand | 366.94 Thousand |
| Income Tax Expense | 3.00 | 2.00 | 1.00 | 3.00 | 438.11 Thousand | 408.47 Thousand |
| Earnings before Tax | -1.46 Million | -1.44 Million | -8.01 Million | -2.2 Million | -2.15 Million | -1.86 Million |
| Net Income | -1.46 Million | -1.44 Million | -8.01 Million | -2.2 Million | -2.15 Million | -1.86 Million |
| Earnings Per Share Basic | -0.07 | -0.09 | - | -0.13 | -0.13 | -0.11 |
| Earnings Per Share Diluted | -0.07 | -0.09 | - | -0.13 | -0.13 | -0.11 |
| Weighted Average Shares Outstanding | 20.75 Million | 16.49 Million | 16.62 Million | 17.64 Million | 16.61 Million | 17.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 20.75 Million | 16.49 Million | 16.62 Million | 17.64 Million | 16.61 Million | 17.64 Million |
| Gross Margin | 0.61 | 0.63 | 0.11 | 0.34 | 0.42 | 0.51 |
| EBIT Margin | -0.53 | -0.64 | - | -1.38 | -2.73 | -1.53 |
| Profit Margin | -1.25 | -1.37 | -3.36 | -2.30 | -6.18 | -4.67 |
| EBITDA | -620.73 Thousand | -673.85 Thousand | - | -1.32 Million | -948.5 Thousand | -609.85 Thousand |
| Earnings Before Tax Margin | -0.86 | -1.00 | -2.33 | -1.84 | -4.07 | -2.69 |
ENTG
ANLBF
MSLA
VRNO
KLRFM
GUJPETR